Loading...
Docoh

Solid Biosciences (SLDB)

News

From Benzinga Pro
What 4 Analyst Ratings Have To Say About Solid Biosciences
19 May 22
Analyst Ratings
Over the past 3 months, 4 analysts have published their opinion on Solid Biosciences (NASDAQ:SLDB) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
Piper Sandler Maintains Neutral on Solid Biosciences, Lowers Price Target to $2
19 May 22
News, Price Target, Analyst Ratings
Piper Sandler analyst Allison Bratzel maintains Solid Biosciences (NASDAQ:SLDB) with a Neutral and lowers the price target from $5 to $2.
Stocks That Hit 52-Week Lows On Wednesday
11 May 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
On Wednesday, 807 companies reached new 52-week lows.
Stocks That Hit 52-Week Lows On Friday
6 May 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
On Friday, 1043 companies hit new 52-week lows.
Stocks That Hit 52-Week Lows On Wednesday
4 May 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
During Wednesday's trading, 435 companies set new 52-week lows.
Looking Into Solid Biosciences's Return On Capital Employed
2 May 22
Earnings
Solid Biosciences (NASDAQ:SLDB) brought in sales totaling $1.93 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 36.1%, resulting in a loss of $25.33 million.
Stocks That Hit 52-Week Lows On Friday
29 Apr 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
On Friday, 213 companies hit new 52-week lows.
10 Biggest Price Target Changes For Thursday
28 Apr 22
Penny Stocks, Price Target, Pre-Market Outlook, Analyst Ratings
Needham lowered MKS Instruments, Inc. (NASDAQ: MKSI) price target from $185 to $175. MKS Instruments shares rose 3.6% to $116.01 in pre-market trading.
Piper Sandler Maintains Neutral on Solid Biosciences, Lowers Price Target to $5
28 Apr 22
News, Price Target, Analyst Ratings
Piper Sandler analyst Allison Bratzel maintains Solid Biosciences (NASDAQ:SLDB) with a Neutral and lowers the price target from $6 to $5.
SVB Leerink Maintains Outperform on Solid Biosciences, Raises Price Target to $15
28 Apr 22
News, Price Target, Analyst Ratings
SVB Leerink analyst Joseph Schwartz maintains Solid Biosciences (NASDAQ:SLDB) with a Outperform and raises the price target from $12 to $15.
Chardan Capital Maintains Buy on Solid Biosciences, Lowers Price Target to $7
28 Apr 22
News, Price Target, Analyst Ratings
Chardan Capital analyst Geulah Livshits maintains Solid Biosciences (NASDAQ:SLDB) with a Buy and lowers the price target from $17 to $7.
62 Biggest Movers From Yesterday
28 Apr 22
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Tenon Medical, Inc. (NASDAQ: TNON) rose 350% to clsoe at $22.50 on Wednesday after the company priced its IPO at $5.00 per share.
Stocks That Hit 52-Week Lows On Wednesday
27 Apr 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
Wednesday's session saw 784 companies set new 52-week lows.
Duchenne Player Solid Biosciences Realigns Pipeline Strategy, Cuts Staff By 35%
27 Apr 22
Biotech, Earnings, News, Penny Stocks, Guidance, Health Care, Movers, Trading Ideas, General
Solid Biosciences Inc (NASDAQ: SLDB) is shaving down its pipeline, updating its operations strategy to prioritize the advancement of AAV-mediated gene transfer therapies, SGT-001 and SGT-003.
Recap: Solid Biosciences Q1 Earnings
27 Apr 22
Earnings, News
Solid Biosciences (NASDAQ:SLDB) reported its Q1 earnings results on Wednesday, April 27, 2022 at 06:00 AM. Here's what investors need to know about the announcement.
The Daily Biotech Pulse: Molecular Partners Plunges On Double Bad News, Pfizer/BioNTech Seek Nod For COVID-19 Shot In Kids, Pfizer Invests In Zentalis
27 Apr 22
Biotech, Earnings, Large Cap, M&A, News, Penny Stocks, Health Care, Financing, Offerings, Small Cap, FDA, Movers, Trading Ideas, General
Here's a roundup of top developments in the biotech space over the last 24 hours.
Earnings Scheduled For April 27, 2022
27 Apr 22
Earnings, News, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • Deutsche Bank (NYSE:DB) is projected to report earnings for its first quarter.
Earnings Outlook For Solid Biosciences
26 Apr 22
Earnings
Solid Biosciences (NASDAQ:SLDB) is set to give its latest quarterly earnings report on Wednesday, 2022-04-27. Here's what investors need to know before the announcement. Analysts estimate that Solid Biosciences will report an earnings per share (EPS) of $-0.18.
23 Stocks Moving in Thursday's Pre-Market Session
31 Mar 22
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers IZEA Worldwide, Inc. (NASDAQ: IZEA) rose 33.3% to $1.92 in pre-market trading after the company reported Q4 EPS results up from last year and better-than-expected sales results.
Solid Biosciences's Return On Capital Employed Insights
16 Mar 22
Earnings
Benzinga Pro data, Solid Biosciences (NASDAQ:SLDB) reported Q4 sales of $3.15 million. Earnings fell to a loss of $18.61 million, resulting in a 3.49% decrease from last quarter.